Open Access. Powered by Scholars. Published by Universities.®

History Commons™

Open Access. Powered by Scholars. Published by Universities.®

2015

History of Science, Technology, and Medicine

University of Texas MD Anderson Cancer Center

Articles 1 - 11 of 11

Full-Text Articles in History

Oncolog, Volume 60, Number 11 - 12, November - December 2015, Joe Munch, Bryan Tutt, C. Graber Nov 2015

Oncolog, Volume 60, Number 11 - 12, November - December 2015, Joe Munch, Bryan Tutt, C. Graber

OncoLog MD Anderson's Report to Physicians (All issues)

  • Multidisciplinary Treatment Maximizes Outcomes for malignant Tumors of the Anterior Skull Base: Malignant tumors of the anterior skull base occur in a delicate area but often need aggressive treatment. Determining the best course of therapy for patients with these tumors takes a multidisciplinary effort.
  • Management of Eyelid and Conjunctival Tumors with Preservation of Slight, Function and Cosmesis: Tumors of the eyelid and extent of disease, and which treatments, if any, are needed after surgical excision depends on several factors, including the potential for metastasis.
  • HOUSE CALL: "Other" Health Risks from Smoking-Besides cancer, tobacco causes many diseases.

Go to article

Oncolog, Volume 60, Number 10, October 2015, Joe Munch, Bryan Tutt, Jill Deisigne, K. Nair Oct 2015

Oncolog, Volume 60, Number 10, October 2015, Joe Munch, Bryan Tutt, Jill Deisigne, K. Nair

OncoLog MD Anderson's Report to Physicians (All issues)

  • New Targeted Therapy Offers Hope to Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm, Related Diseases: The treatment of common hematological malignancies is based on reams of study data and years of physician experience with the diseases. But such information is often limited for rare, little-researched blood cancers like blastic plasmacytoid dendritic cell neoplasm (BPDCN). This situation may soon change, thanks to the discovery of a new molecular target, which has led to a spate of innovative treatment approaches and the first dedicated clinical trials for this uncommon malignancy.
  • Laparoscopic Free Omental Lymphatic Flap Transfers Offer a Powerful Alternative for Lymphedema …

Go to article

Oncolog, Volume 60, Number 09, September 2015, Sarah Bronson, Bryan Tutt, K. Nair Sep 2015

Oncolog, Volume 60, Number 09, September 2015, Sarah Bronson, Bryan Tutt, K. Nair

OncoLog MD Anderson's Report to Physicians (All issues)

  • Enhanced Surgical Recovery Programs Improve Perioperative Outcomes for Cancer Patients: For patients undergoing cancer surgery, potential complications and long recovery times can delay the delivery of additional life-saving therapy. To improve patients' perioperative outcomes and clear the way for timely administration of additional therapies, several surgical teams at The University of Texas MD Anderson Cancer Center gave begun using enhanced surgical recovery programs (ESRPs).
  • New Treatments for Respiratory Viruses in Immunocompromised Patients: Viral respiratory infections are a major concern for immunocompromised patients, in whom such infections are difficult to treat and can lead to pneumonia and even death. Although few …

Go to article

Oncolog, Volume 60, Number 08, August 2015, Stephanie Deming, Bryan Tutt, K. Nair Aug 2015

Oncolog, Volume 60, Number 08, August 2015, Stephanie Deming, Bryan Tutt, K. Nair

OncoLog MD Anderson's Report to Physicians (All issues)

  • New Gene Therapy for Bladder Cancer Shows Promise: A gene therapy that stimulates interferon production within the body may prove to be effective against high-risk, early-stage bladder cancer when standard treatment fails.
  • Vaccine Helps T Cells Target Sarcomas, Melanomas and other Tumors: A vaccine that delivers an antigen to dendritic cells, in turn activating killer T cells that can target specific cancers, is the subject of two ongoing clinical trials,
  • INBRIEF: Glypican-1 Shows Promise as a Biomarker for Pancreatic Cancer/Stereotactic Ablative Radiation Therapy for Stage I Non-Small Cell Lung Cancer May Offer Survival Benefit
  • HOUSE CALL: Prostate Cancer Screening-Who should …

Go to article

Oncolog, Volume 60, Number 07, July 2015, Kathryn L. Hale, Bryan Tutt, K. Stuyck Jul 2015

Oncolog, Volume 60, Number 07, July 2015, Kathryn L. Hale, Bryan Tutt, K. Stuyck

OncoLog MD Anderson's Report to Physicians (All issues)

  • Emergency Care for Cancer Patients: Medical problems that may seem routine in patients without cancer often mean something different or have a different cause in cancer patients and may be much more serious, requiring urgent treatment. Managing these problems promptly and effectively is a challenge faced by all cancer centers.
  • Immunotherapy Trials Offer Hope to Patients with High-Risk or Metastatic Cancer: Although the cure rate for the breast cancer has risen steadily in recent decades, recurrent or metastatic disease remains difficult to control. To fight metastatic breast cancer and forestall the recurrence of high-risk primary disease, researchers at The University …

Go to article

Oncolog, Volume 60, Number 06, June 2015, Bryan Tutt, Joe Munch, U. Arizor Jun 2015

Oncolog, Volume 60, Number 06, June 2015, Bryan Tutt, Joe Munch, U. Arizor

OncoLog MD Anderson's Report to Physicians (All issues)

  • New Breast Imaging Modalities Show promise for Cancer Screening and Staging: New technology to supplement digital mammography may improve breast cancer screening and diagnosis. Although some of these new imaging modalities are still under development, others are already in clinical use as adjuncts to mammography for breast cancer screening and staging.
  • Addressing Sexual Dysfunction in Cancer Survivors: Cancer treatments carry a host of side effects that can affect patients' ability to have and enjoy sex. The sexual dysfunction arising from these side effects, which include functional changes, can often be addressed, but uncovering sexual dysfunction can prove challenging.
  • HOUSE CALL: …

Go to article

Oncolog, Volume 60, Number 05, May 2015, Sarah Bronson, Bryan Tutt, U. Arizor May 2015

Oncolog, Volume 60, Number 05, May 2015, Sarah Bronson, Bryan Tutt, U. Arizor

OncoLog MD Anderson's Report to Physicians (All issues)

  • Algorithm for Treating Advanced Ovarian Cancer Increases Complete Resection Rate: Most ovarian cancers have spread beyond the ovary by the time they are diagnosed, and they often recur even after responding to primary treatment. Researchers at The University of Texas MD Anderson Cancer Center aim to improve patient outcomes by changing the standard approach to newly diagnosed advanced ovarian cancer.
  • Clinical Trials Explore Systemic Treatments for Brain Metastases from Breast Cancer: Brain metastases from breast cancer are difficult to treat because many of the systemic drugs that are effective against breast cancer cannot cross the blood-brain barrier. But researchers at …

Go to article

Oncolog, Volume 60, Number 04, April 2015, Jill Deisigne, Joe Munch, Bryan Tutt, Sarah Bronson Apr 2015

Oncolog, Volume 60, Number 04, April 2015, Jill Deisigne, Joe Munch, Bryan Tutt, Sarah Bronson

OncoLog MD Anderson's Report to Physicians (All issues)

  • Multidisciplinary Globe-Sparing Treatment for Lacrimal Gland Carcinoma Preserves Vision and Minimizes Morbidity: Until recently, the treatment of lacrimal gland carcinoma almost always required removal of the eye. But for some patients with these tumors, globe-sparing surgery followed by radiation therapy can preserve vision and decrease ocular morbidity and facial disfigurement.
  • Novel Trial Design Streamlines Development of Breast Cancer Therapies: Developing a cancer-fighting drug can take around a billion dollars and a dozen or more years. Even then, fail in clinical trials. To identify effective cancer therapies more quickly and efficiently, researchers have tuned to an innovative clinical model in which …

Go to article

Oncolog, Volume 60, Number 03, March 2015, Bryan Tutt, Kathryn L. Hale, K. Stuyck Mar 2015

Oncolog, Volume 60, Number 03, March 2015, Bryan Tutt, Kathryn L. Hale, K. Stuyck

OncoLog MD Anderson's Report to Physicians (All issues)

  • Small Cell Lung Cancer Studies May Increase Treatment Options: Despite advances in treating many cancers, the standard treatment of small cell lung cancer has remained unchanged for decades. But researchers at The University of Texas MD Anderson Cancer Center are exploring several new approaches to treat small cell lung cancer.
  • Improved Maintenance Therapy Promotes Myeloma patients' Quality of Life After Stem Cell Transplantation: High-dose chemotherapy followed by autologous stem cell transplantation can prolong survival for patients with multiple myeloma. However, patients remain at a high risk of relapse even after transplantation. Maintenance therapy can extend remission in these patients, and …

Go to article

Oncolog, Volume 60, Number 02, February 2015, Sarah Bronson, Bryan Tutt, N. Danckers Feb 2015

Oncolog, Volume 60, Number 02, February 2015, Sarah Bronson, Bryan Tutt, N. Danckers

OncoLog MD Anderson's Report to Physicians (All issues)

  • Natural Killer Cell Therapy May Augment Treatment of Hematological Cancers: Tough cancer treatments can severely weaken the body's natural ability to attack cancer cells. To improve immune recovery and function in patients who have undergone these treatments, especially those who may later receive a stem cell transplant, researchers are turning to natural killer cells that have been expanded in the laboratory.
  • Concurrent Treatment of HIV and Cancer Improves Survival Outcomes: Concurrent HIV and cancer present special challenges in the clinic, regardless of which disease is diagnosed first. The simultaneous treatment of HIV and cancer is complicated by patients' weakened immune …

Go to article

Oncolog, Volume 60, Number 01, January 2015, Bryan Tutt, Markeda Wade, Bryan Tutt, N. Danckers Jan 2015

Oncolog, Volume 60, Number 01, January 2015, Bryan Tutt, Markeda Wade, Bryan Tutt, N. Danckers

OncoLog MD Anderson's Report to Physicians (All issues)

  • Simultaneous Resection of Liver and Lung Metastases from Colorectal Cancer Eliminates Need for Second Surgery: Patients with colorectal cancer metastases to the liver and one or both lungs often face the unwelcome prospect of two operations and two recovery periods. But a novel surgical approach enables the liver and lung lesion resections to be performed during the same operation.
  • Some Breast Cancer Patients May Benefit from Shorter Course of Whole-Breast Irradiation: A shorter course of radiation therapy at higher doses per fraction than the standard regimen could reduce side effects and improve quality of life for some patients with breast …

Go to article